Wednesday, October 9, 2024

HomeHealth NewsTargeted therapy may help treat moderate to severe ulcerative colitis: trial

Targeted therapy may help treat moderate to severe ulcerative colitis: trial

- Advertisement -

New research is testing the medication tulisokibart in treating ulcerative colitis. Maria Korneeva/Getty Images
  • Ulcerative colitis is a type of inflammatory bowel disease (IBD) and often involves unpleasant digestive symptoms such as pain, cramping, and diarrhea.
  • Researchers are interested in finding the most effective medications to treat ulcerative colitis.
  • One study found that the medication tulisokibart may help people with moderate to severe ulcerative colitis achieve clinical remission.

Click here to view the original article.

- Advertisment -

Recently Viewed